Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/2003
06/24/2003US6582747 Dry cocoa mix containing a mixture of non-alkalized and alkalized cocoa solids
06/24/2003US6582688 Method for extracting compounds of furan lipids and polyhydroxylated fatty alcohols of avocado, composition based on said compounds, and therapeutic, cosmetical or food use of said compounds
06/24/2003US6582351 Benzimidazole heterocyclic compounds having pharmacological activities, and their use as a medicament for treatment or prevention of diseases mediated by cGMP-PDE
06/24/2003CA2343439C Compositions useful in the treatment of diseases of connective tissues
06/24/2003CA2288910C Pyrazolopyrimidinones for sexual dysfunction
06/24/2003CA2223694C Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
06/24/2003CA2179015C Use of bis(amidinobenzimidazoles) in the manufacture of medicament for inhibiting retroviral integrase
06/24/2003CA2130805C Use of mannose phosphates for the treatment of fibrotic disorders
06/24/2003CA1341433C Purification of interleukin 1
06/21/2003CA2414905A1 N-(cyclopropylmethyl)azacycloalkanes, compositions containing them and methods of preparation
06/19/2003WO2003050267A2 Method of isolating extract from the euphorbaciae obesa plant and methods for using the same
06/19/2003WO2003050255A2 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
06/19/2003WO2003050251A2 Hematopoietic cells from human embryonic stem cells
06/19/2003WO2003050128A1 Phosphonates useful as modulators of t $g(g)9$g(d)2 lymphocyte activity
06/19/2003WO2003050123A1 Fused bicyclic pyridine derivatives as tachykinin receptor antagonists
06/19/2003WO2003050121A1 Thioether substituted imidazoquinolines
06/19/2003WO2003050119A2 Urea substituted imidazopyridines
06/19/2003WO2003050118A1 Amide substituted imidazopyridines
06/19/2003WO2003050117A1 Sulfonamido substituted imidazopyridines
06/19/2003WO2003050108A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
06/19/2003WO2003050101A1 Deuterated substituted dihydrofuranones and medicaments containing these compounds
06/19/2003WO2003050099A1 Phenylalkynes
06/19/2003WO2003050097A1 Sodium salt of benzyl thiazolidine-2,4-dione derivative and hydrate thereof
06/19/2003WO2003050093A1 Bis(cyanophenyl)methyl-triazole for use in prevention of breast cancer
06/19/2003WO2003050085A1 CRYSTALLINE [R-(R*,R*)]-2-(4-FLUOROPHENYL)-β,δ-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-HEPTANOIC ACID CALCIUM SALT (2:1)
06/19/2003WO2003050073A1 Substituted hydroxyethylamines
06/19/2003WO2003050067A2 Vitamin d analogues
06/19/2003WO2003049804A2 Treatment of genitourinary tract disorders
06/19/2003WO2003049773A1 Methods for inhibiting ocular processes
06/19/2003WO2003049772A2 Guanidinium transport reagents and conjugates
06/19/2003WO2003049769A2 Method for reducing acne or improving skin tone
06/19/2003WO2003049760A1 Compositions and method for treating hepatitis virus infection
06/19/2003WO2003049746A2 Combination of cytochome p450 dependent protease inhibitors
06/19/2003WO2003049745A1 Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists
06/19/2003WO2003049742A1 Method for administering birb 796 bs
06/19/2003WO2003049741A1 Ureas of 2-aminobenzothiazoles as adenosine modulators
06/19/2003WO2003049740A1 Quinazoline derivatives for the treatment of abnormal cell growth
06/19/2003WO2003049739A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003WO2003049738A1 Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition
06/19/2003WO2003049734A1 Compositions comprising epothilones and their use for the treatment of carcinoid syndrome
06/19/2003WO2003049730A1 Treatment of statin side effects using uridine derivatives
06/19/2003WO2003049724A1 Use of norepinephrine reuptake inhibitors for the treatment of cognitive failure
06/19/2003WO2003049718A1 Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist
06/19/2003WO2003049717A2 Conductance of improperly folded proteins through the secretory pathway and related treatments of diseases
06/19/2003WO2003049703A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003WO2003049698A2 Substituted hydrazones as inhibitors of cyclooxygenase-2
06/19/2003WO2003049690A2 Hiv integrase inhibitors
06/19/2003WO2003049686A2 Stabilization of hypoxia inducible factor (hif) alpha
06/19/2003WO2003049682A2 Composition and method for treating chronic allograft rejection
06/19/2003WO2003049680A2 Compositions containing both sedative and non-sedative antihistamines
06/19/2003WO2003049679A2 Mitotic kinesin inhibitors
06/19/2003WO2003049678A2 Mitotic kinesin inhibitors
06/19/2003WO2003049673A2 Methods and compositions for control of bone formation via modulation of sympathetic tone
06/19/2003WO2003049593A2 Prevention of flap necrosis in plastic surgery
06/19/2003WO2003049527A2 Mitotic kinesin inhibitors
06/19/2003WO2003039480A3 Method of treating disorder related to high cholesterol concentration
06/19/2003WO2003028650A3 Benzimidazolidinone derivatives as muscarinic agents
06/19/2003WO2003013438A3 Nutrient therapy for immuno-compromised patients
06/19/2003WO2003009777A3 Delivery of therapeutic capable agents
06/19/2003WO2003007882A3 Method of making bowman-birk inhibitor product
06/19/2003WO2003005960A3 Novel bicyclic and tricyclic cannabinoids
06/19/2003WO2002094864A3 Human cdnas and proteins and uses thereof
06/19/2003WO2002088172B1 Pentapeptide compounds and uses related thereto
06/19/2003WO2002077237A3 Transporters and ion channels
06/19/2003WO2002051429A3 Use of a composition for the stimulation of nerve growth, the inhibition of scar tissue formation, the reduction of secondary damage and/or the accumulation of macrophages
06/19/2003WO2002048172A3 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus
06/19/2003WO2002034899A3 Tec kinase assay
06/19/2003WO2002008244A3 Peptides as ns3-serine protease inhibitors of hepatitis c virus
06/19/2003WO2001015676A9 Compositions and methods for modulating hdl cholesterol and triglyceride levels
06/19/2003WO2001008635A3 Calcium channel transport polynucleotides, polypeptides, and antibodies
06/19/2003US20030114683 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors
06/19/2003US20030114678 Cardioprotective phosphonates and malonates
06/19/2003US20030114677 Cardioprotective phosphonates and malonates
06/19/2003US20030114668 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists
06/19/2003US20030114658 Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of use
06/19/2003US20030114646 Human cystatin F
06/19/2003US20030114529 HO-NH-(C=O)-CH2-CH(-CH2-CH(CH3)2)-(C=O)-V-,V=valine or another amino acid connected with an amino acid sequence of 10 or more amino acids; useful for treating diseases caused by cartilage degradation
06/19/2003US20030114527 Administering an immediate release tablets containing 400 mg of 5-methyl-2-(2'- chloro-6'-fluoroanilino)phenylacetic acid or salts to a patient for the treatment of cyclooxygenase-2 mediated diseases
06/19/2003US20030114521 Oxamic acids and derivatives as thyroid receptor ligands
06/19/2003US20030114513 Use of isatin derivatives as ion channel activating agents
06/19/2003US20030114505 Novel isoxazole and thiazole compounds and use thereof as drugs
06/19/2003US20030114504 Compositions and methods for the treatment of cancer
06/19/2003US20030114497 Pharmaceutical compositions of amlodipine and atorvastatin
06/19/2003US20030114492 Method of using neurotrophic sulfonamide compounds
06/19/2003US20030114478 Asthma therapy; antiinflammatory agents
06/19/2003US20030114473 Anticancer agents
06/19/2003US20030114470 Crystalline forms of valacyclovir hydrochloride
06/19/2003US20030114469 Combinations
06/19/2003US20030114468 Psychological disorders
06/19/2003US20030114464 Synergistic mixture containing quinolone antibiotic such as floxacin; also fungicide; topical applying to eye
06/19/2003US20030114461 Cyclization 1,4-diazabicyclo(3,2,2)nonane with isooxazole compound
06/19/2003US20030114460 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics
06/19/2003US20030114459 Synergistic mixture with prostaglandins; analgesics
06/19/2003US20030114458 Antibacterial agents
06/19/2003US20030114456 Antiinflammatory agents, analgesics, antipyretics
06/19/2003US20030114455 Sexual disorders
06/19/2003US20030114453 Antiinflammatory agents; asthma; skin disorders
06/19/2003US20030114449 Saccharin derivatives as orally active elastase inhibitors
06/19/2003US20030114443 Viricides, Aids therapy
1 ... 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 ... 1564